Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Won Gu

Showing results (211-220 of 333) with videos related to

Pageof 34
Sort By:
Endocrinology and Metabolism (Seoul, Korea)|February 2, 2018
Comparison of Immunohistochemistry and Direct Sanger Sequencing for Detection of the BRAF(V600E) Mutation in Thyroid NeoplasmHye Seon Oh, Hyemi Kwon, Suyeon Park, et al.
Thyroid : Official Journal of the American Thyroid Association|September 15, 2012
Long-term consequence of elevated thyroglobulin in differentiated thyroid cancerJi Hye Yim, Eui Young Kim, Won Bae Kim, et al.
The Journal of Biological Chemistry|April 12, 2012
Orphan nuclear receptor chicken ovalbumin upstream promoter-transcription factor II (COUP-TFII) protein negatively regulates bone morphogenetic protein 2-induced osteoblast differentiation through suppressing runt-related gene 2 (Runx2) activityKkot-Nim Lee, Won-Gu Jang, Eun-Jung Kim, et al.
The Journal of Clinical Endocrinology and Metabolism|November 5, 2016
Initial and Dynamic Risk Stratification of Pediatric Patients With Differentiated Thyroid CancerTae Yon Sung, Min Ji Jeon, Yi Ho Lee, et al.
Head & Neck|January 20, 2019
Impact of tumor-associated macrophages and BRAF<sup>V600E</sup> mutation on clinical outcomes in patients with various thyroid cancersJae Won Cho, Won Woong Kim, Yu-Mi Lee, et al.
Thyroid : Official Journal of the American Thyroid Association|January 20, 2018
Tertiary Care Experience of Sorafenib in the Treatment of Progressive Radioiodine-Refractory Differentiated Thyroid Carcinoma: A Korean Multicenter StudyMijin Kim, Tae Hyuk Kim, Dong Yeob Shin, et al.
The Journal of Clinical Endocrinology and Metabolism|September 25, 2008
Change of serum antithyroglobulin antibody levels is useful for prediction of clinical recurrence in thyroglobulin-negative patients with differentiated thyroid carcinomaWon Gu Kim, Jong Ho Yoon, Won Bae Kim, et al.
Journal of Surgical Oncology|June 2, 2017
Preoperative clinicopathological characteristics of patients with solitary encapsulated follicular variants of papillary thyroid carcinomasHyemi Kwon, Min Ji Jeon, Jong Ho Yoon, et al.
European Journal of Endocrinology|June 9, 2016
Early prognostic factors at the time of diagnosis of bone metastasis in patients with bone metastases of differentiated thyroid carcinomaYun Mi Choi, Won Gu Kim, Hyemi Kwon, et al.
Thyroid : Official Journal of the American Thyroid Association|May 1, 2019
Quality of Life in Patients with Papillary Thyroid Microcarcinoma Managed by Active Surveillance or Lobectomy: A Cross-Sectional StudyMin Ji Jeon, Yu-Mi Lee, Tae-Yon Sung, et al.
Pageof 34

Showing results (211-220 of 333) with videos related to

Sort By:
Pageof 34
Endocrinology and Metabolism (Seoul, Korea)|February 2, 2018
Comparison of Immunohistochemistry and Direct Sanger Sequencing for Detection of the BRAF(V600E) Mutation in Thyroid NeoplasmHye Seon Oh, Hyemi Kwon, Suyeon Park, et al.
Thyroid : Official Journal of the American Thyroid Association|September 15, 2012
Long-term consequence of elevated thyroglobulin in differentiated thyroid cancerJi Hye Yim, Eui Young Kim, Won Bae Kim, et al.
The Journal of Biological Chemistry|April 12, 2012
Orphan nuclear receptor chicken ovalbumin upstream promoter-transcription factor II (COUP-TFII) protein negatively regulates bone morphogenetic protein 2-induced osteoblast differentiation through suppressing runt-related gene 2 (Runx2) activityKkot-Nim Lee, Won-Gu Jang, Eun-Jung Kim, et al.
The Journal of Clinical Endocrinology and Metabolism|November 5, 2016
Initial and Dynamic Risk Stratification of Pediatric Patients With Differentiated Thyroid CancerTae Yon Sung, Min Ji Jeon, Yi Ho Lee, et al.
Head & Neck|January 20, 2019
Impact of tumor-associated macrophages and BRAF<sup>V600E</sup> mutation on clinical outcomes in patients with various thyroid cancersJae Won Cho, Won Woong Kim, Yu-Mi Lee, et al.
Thyroid : Official Journal of the American Thyroid Association|January 20, 2018
Tertiary Care Experience of Sorafenib in the Treatment of Progressive Radioiodine-Refractory Differentiated Thyroid Carcinoma: A Korean Multicenter StudyMijin Kim, Tae Hyuk Kim, Dong Yeob Shin, et al.
The Journal of Clinical Endocrinology and Metabolism|September 25, 2008
Change of serum antithyroglobulin antibody levels is useful for prediction of clinical recurrence in thyroglobulin-negative patients with differentiated thyroid carcinomaWon Gu Kim, Jong Ho Yoon, Won Bae Kim, et al.
Journal of Surgical Oncology|June 2, 2017
Preoperative clinicopathological characteristics of patients with solitary encapsulated follicular variants of papillary thyroid carcinomasHyemi Kwon, Min Ji Jeon, Jong Ho Yoon, et al.
European Journal of Endocrinology|June 9, 2016
Early prognostic factors at the time of diagnosis of bone metastasis in patients with bone metastases of differentiated thyroid carcinomaYun Mi Choi, Won Gu Kim, Hyemi Kwon, et al.
Thyroid : Official Journal of the American Thyroid Association|May 1, 2019
Quality of Life in Patients with Papillary Thyroid Microcarcinoma Managed by Active Surveillance or Lobectomy: A Cross-Sectional StudyMin Ji Jeon, Yu-Mi Lee, Tae-Yon Sung, et al.
Pageof 34